Market Overview:
The U.S. medical foods market comprises specialty formulated food products that are intended for the dietary management of diseases or health conditions under medical supervision. Medical foods aim to fulfill distinctive nutritional requirements for a disease or disorder when conventional foods alone cannot. Some common examples include food products designed to manage inherited metabolic disorders, HIV/AIDS wasting, diabetes, depression, Alzheimer’s disease, and pulmonary diseases. There has been a rise in the prevalence of chronic metabolic disorders such as diabetes and obesity among the U.S. population in recent years. Medical foods provide a useful dietary option to manage the nutritional needs associated with these conditions. The market offers customized food products that resemble conventional foods and serve as a more palatable alternative to dietary supplements.
The U.S. Medical Foods Market is estimated to be valued at US$ 25722.45 Bn in 2024 and is expected to exhibit a CAGR of 21% over the forecast period 2024 to 2030.
Key Takeaways:
Key players operating in the U.S. medical foods are Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc. These leaders are focusing on new product launches and acquisitions to strengthen their market position. For instance, in 2022, Magellan Health acquired Med Allies grocery delivery service to expand its medical foods delivery platform.
There is high demand for customized medical nutrition products that cater to the specific needs of individuals. Manufacturers are investing in personalized formulations and precision nutrition approaches using ingredients like prebiotics, probiotics, and microbiome-targeted therapies. The growing geriatric population and proliferating chronic disease prevalence also present opportunities for new clinical indications and partnerships with healthcare providers.
The medical foods market has gained significant traction in the US but players are also exploring opportunities in global regions. Favorable regulatory systems and reimbursement policies and the increasing incidence of metabolic disorders in countries like China, Japan and Australia due to lifestyle changes are encouraging companies to expand their international footprint. Partnerships, joint ventures and acquisitions remain key strategies for overseas market penetration.
Market Drivers:
The key driver for the U.S. medical food market is the increasing prevalence of metabolic disorders. According to CDC reports, nearly 40% of the US adult population is clinically obese and over 34 million Americans have diabetes. Medical foods support the dietary management of these conditions. Moreover, rising healthcare costs have amplified demand for lower cost alternatives like medical nutrition to mainstream clinical care. Publications demonstrating the healthcare cost savings and effectiveness of specialty formulated foods in chronic disease management further support market growth.
Market Restrains:
A major challenge is the limited awareness about medical foods among healthcare professionals and consumers. Many view them as substitutes for pharmacological interventions. Moreover, not all medical food products are eligible for insurance coverage or reimbursement which constrain their uptake. Formulation complexities and stringent regulatory clearances associated with proprietary ingredient formulations also increase the barriers for new entrants. High R&D costs needed to demonstrate efficacies as per FDA guidelines pose another challenge for market players.
Segment Analysis
The U.S.Medical Foods Market Demand is dominated by the therapeutic foods and beverages segment which accounts for over 60% of the market share. This is because most of the medical foods that are prescribed target conditions like pulmonary disorders, gastrointestinal diseases, dental disease, inborn errors of metabolism, and attention deficit hyperactivity disorder, all of which can be effectively managed through specially formulated drinks and food supplements. The ease of consumption of therapeutic foods and beverages makes it a preferred choice over other segments like pills or capsules.
Global Analysis
The North American region holds the largest share in the global medical foods market due to superior healthcare infrastructure and availability of advanced treatment options. Within North America, the United States dominates and accounts for over 85% of the regional market share. This is because of presence of major players, strong distribution network of medical foods and rising prevalence of chronic and genetic diseases. The Asia Pacific region is poised to grow at the fastest rate during the forecast period owing to growing medical tourism, rising healthcare spending and increasing awareness about nutrition-based disease management in countries like China, India and South Korea.
For more insights, read- U.S. Medical Foods Market
Check more trending articles related to this topic: Global Panic Attack Treatment Market
Comments
0 comment